PL3375448T3 - Szczep posiadający zdolność do hamowania otyłości i zawierająca go kompozycja farmaceutyczna - Google Patents
Szczep posiadający zdolność do hamowania otyłości i zawierająca go kompozycja farmaceutycznaInfo
- Publication number
- PL3375448T3 PL3375448T3 PL16864537T PL16864537T PL3375448T3 PL 3375448 T3 PL3375448 T3 PL 3375448T3 PL 16864537 T PL16864537 T PL 16864537T PL 16864537 T PL16864537 T PL 16864537T PL 3375448 T3 PL3375448 T3 PL 3375448T3
- Authority
- PL
- Poland
- Prior art keywords
- strain
- ability
- pharmaceutical composition
- composition containing
- containing same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150020316 | 2015-02-10 | ||
| KR1020150156733A KR102125548B1 (ko) | 2015-02-10 | 2015-11-09 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
| EP16864537.2A EP3375448B1 (en) | 2015-02-10 | 2016-11-08 | Strain having ability to inhibit obesity and pharmaceutical composition containing same |
| PCT/KR2016/012791 WO2017082611A1 (ko) | 2015-02-10 | 2016-11-08 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3375448T3 true PL3375448T3 (pl) | 2022-01-10 |
Family
ID=56874996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16864537T PL3375448T3 (pl) | 2015-02-10 | 2016-11-08 | Szczep posiadający zdolność do hamowania otyłości i zawierająca go kompozycja farmaceutyczna |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11273188B2 (pl) |
| EP (1) | EP3375448B1 (pl) |
| KR (2) | KR102125548B1 (pl) |
| ES (1) | ES2839216T3 (pl) |
| PL (1) | PL3375448T3 (pl) |
| WO (1) | WO2017082611A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
| JP6684966B2 (ja) * | 2016-09-30 | 2020-04-22 | シージェイ チェイルジェダン コーポレイション | 新規なラクトバチルス・サケイ及びそれを含む組成物 |
| TWI645854B (zh) * | 2017-03-20 | 2019-01-01 | 大江生醫股份有限公司 | 胚芽乳酸桿菌tci378及其於減脂及改善腸胃功能之應用 |
| KR101873239B1 (ko) * | 2017-10-13 | 2018-07-04 | 주식회사 지놈앤컴퍼니 | 락토바실러스 파라카제이 lm1010 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물 |
| KR101980527B1 (ko) | 2018-03-26 | 2019-05-21 | 주식회사 지놈앤컴퍼니 | 신규한 락토바실러스 퍼멘텀 lm1016 균주, 및 이를 포함하는 심혈관질환 예방 또는 치료용 조성물 |
| KR102043740B1 (ko) * | 2018-11-19 | 2019-11-12 | 주식회사한국야쿠르트 | 알코올성 지방간 개선 효능을 갖는 락토바실러스 파라카제이 hy7014 및 이를 유효성분으로 함유하는 제품 |
| CN110205261B (zh) * | 2019-05-10 | 2020-08-04 | 湖南菲勒生物技术有限公司 | 一种母乳来源罗伊氏乳杆菌降脂及调节脂代谢节律的应用 |
| KR102344838B1 (ko) * | 2019-11-22 | 2021-12-28 | 이진영 | 항균 및 항비만 활성을 갖는 락토바실러스 플란타룸 yg1102 균주 및 이의 용도 |
| US12290540B2 (en) | 2019-11-29 | 2025-05-06 | Jinis Co., Ltd | Strain having ability to lower blood ammonia levels and composition comprising same for neuronal protection |
| AU2020417121B2 (en) * | 2019-12-31 | 2024-05-02 | Gi Biome | Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases containing same |
| KR102128098B1 (ko) * | 2020-03-23 | 2020-06-30 | 주식회사 종근당바이오 | 락토바실러스 델브루키 subsp. 락티스 CKDB001 균주, 및 이를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물 |
| KR102136335B1 (ko) * | 2020-03-24 | 2020-07-22 | (주)메디톡스 | 간기능 개선 또는 지방축적 억제 미생물 및 그의 용도 |
| KR102191487B1 (ko) * | 2020-06-19 | 2020-12-15 | (주)메디톡스 | 간기능 개선 또는 지방축적 억제 미생물 및 그의 용도 |
| TWI783379B (zh) * | 2021-02-19 | 2022-11-11 | 豐華生物科技股份有限公司 | 抗肥胖的乳酸菌菌株組成物及其應用 |
| CN115449520B (zh) * | 2021-06-09 | 2024-08-30 | 杭州芳韵生物科技有限公司 | 一种抗虫基因和耐草甘膦基因表达载体及其应用 |
| JP2024529268A (ja) * | 2021-06-30 | 2024-08-06 | ジーアイ バイオーム インク. | ラクトバチルス属の菌株3種を含む組成物、およびその用途 |
| KR102505232B1 (ko) * | 2021-06-30 | 2023-03-03 | 주식회사 지아이바이옴 | 락토바실러스 속 균주 3종을 포함하는 조성물 및 이의 용도 |
| KR20240169174A (ko) * | 2023-05-23 | 2024-12-03 | 씨제이제일제당 (주) | 락토바실러스 말리 균주 및 이의 용도 |
| CN117431189B (zh) * | 2023-12-08 | 2024-03-15 | 千禾味业食品股份有限公司 | 一株副干酪乳杆菌副干酪亚种菌株qh-20029及其应用 |
| KR102874308B1 (ko) * | 2024-09-09 | 2025-10-22 | (주)에이스바이옴 | 신규한 리모실락토바실러스 퍼멘텀 abf21069 균주와 이를 포함하는 비알코올성 지방간 질환의 예방, 개선 및 항염활성 조성물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3843200A (en) | 1999-04-27 | 2000-11-10 | Kabushiki Kaisha Yakult Honsha | Conjugated fatty acid esters |
| KR100794702B1 (ko) | 2003-07-21 | 2008-01-14 | (주)바이오니아 | 비만증 또는 당뇨병 예방 및/또는 치료용 미생물 |
| KR100794701B1 (ko) | 2002-08-09 | 2008-01-14 | (주)바이오니아 | 비만 또는 당뇨 예방 및 치료용 미생물 |
| KR20040027180A (ko) * | 2002-09-27 | 2004-04-01 | (주)바이오니아 | 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법 |
| KR100543114B1 (ko) | 2003-09-15 | 2006-01-20 | 주식회사한국야쿠르트 | 바실러스 서브틸리스 케이와이 912 |
| US7001756B1 (en) | 2004-02-19 | 2006-02-21 | Genmont Biotech Inc. | Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
| KR100686557B1 (ko) * | 2004-08-16 | 2007-02-23 | 씨제이 주식회사 | 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품 |
| KR100686558B1 (ko) | 2004-09-02 | 2007-02-23 | 씨제이 주식회사 | 체지방 저하 기능성 락토바실러스 플랜타륨와 이를 함유한 식품 |
| CN102225078B (zh) * | 2005-07-26 | 2012-12-26 | 内斯特克有限公司 | 抗肥胖剂及抗肥胖食品 |
| PL1981516T3 (pl) | 2006-01-27 | 2019-03-29 | Dupont Nutrition Biosciences Aps | Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom |
| US8309076B2 (en) | 2006-08-04 | 2012-11-13 | Bioneer Corporation | Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation |
| JP2008214253A (ja) | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
| EP2022502A1 (en) | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
| EP2227239A2 (en) * | 2007-12-06 | 2010-09-15 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
| ATE537707T1 (de) | 2008-05-16 | 2012-01-15 | Nestec Sa | Lactobacillus paracasei und gewichtskontrolle |
| EP2216035A1 (en) | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus rhamnosus CNCM I-4096 and weight control |
| EP2216034A1 (en) | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus helveticus CNCM I-4095 and weight control |
| EP2216036A1 (en) | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control |
| KR101292714B1 (ko) * | 2009-03-10 | 2013-08-05 | 주식회사 지니스 | 미생물을 이용한 비만 및 비만으로 야기된 대사성 질환의 예방과 치료 |
| KR101426275B1 (ko) | 2014-04-04 | 2014-08-06 | 주식회사한국야쿠르트 | 지방합성 억제 및 지방산화 촉진에 의한 체지방 감소 효능을 갖는 5종의 유산균 복합균주를 유효성분으로 함유하는 조성물 |
| KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
-
2015
- 2015-11-09 KR KR1020150156733A patent/KR102125548B1/ko active Active
-
2016
- 2016-11-08 EP EP16864537.2A patent/EP3375448B1/en active Active
- 2016-11-08 ES ES16864537T patent/ES2839216T3/es active Active
- 2016-11-08 PL PL16864537T patent/PL3375448T3/pl unknown
- 2016-11-08 US US15/774,328 patent/US11273188B2/en active Active
- 2016-11-08 WO PCT/KR2016/012791 patent/WO2017082611A1/ko not_active Ceased
-
2018
- 2018-07-25 KR KR1020180086630A patent/KR20180088353A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017082611A1 (ko) | 2017-05-18 |
| US20200061132A1 (en) | 2020-02-27 |
| ES2839216T3 (es) | 2021-07-05 |
| EP3375448A1 (en) | 2018-09-19 |
| KR102125548B1 (ko) | 2020-06-24 |
| EP3375448A4 (en) | 2019-04-24 |
| US11273188B2 (en) | 2022-03-15 |
| KR20160098955A (ko) | 2016-08-19 |
| EP3375448B1 (en) | 2020-09-30 |
| KR20180088353A (ko) | 2018-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3375448T3 (pl) | Szczep posiadający zdolność do hamowania otyłości i zawierająca go kompozycja farmaceutyczna | |
| ZA201802125B (en) | Pharmaceutical composition and application thereof | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| PL3102555T3 (pl) | Kompozycje związków i ich zastosowania | |
| IL290114A (en) | Pharmaceutical preparations, their preparation and uses | |
| EP3175847A4 (en) | Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties | |
| IL235415A0 (en) | Energetic substances and mixtures containing them | |
| PL3323413T3 (pl) | Kompozycja farmaceutyczna zawierająca celekoksyb i tramadol | |
| PT3278801T (pt) | Composição farmacêutica que contém mirabegron | |
| IL252397A0 (en) | Pharmaceutical preparations, their preparation and uses | |
| PL3229843T3 (pl) | Kompozycja farmaceutyczna, wytwarzanie i zastosowanie tej kompozycji | |
| SG11201704486TA (en) | Improvements in and relating to the treatment of matrices and/or the contents of matrices | |
| GB201406172D0 (en) | Therapy and pharmaceutical composition | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| GB201421261D0 (en) | Improvements in and relating to the processing of matrices and/or the contents of matrices | |
| ZA201703078B (en) | Pharmaceutical composition comprising bisoprolol and perindoril | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| IL251478B (en) | A pharmaceutical compound containing budesonide and formoterol | |
| GB201522814D0 (en) | Compositions and uses thereof | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| GB201604810D0 (en) | Pharmaceutical compositions and uses | |
| AP2017009817A0 (en) | Capsaicinoids and uses thereof as medicaments |